Re: Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial

被引：0
|
作者：
Resnick, Matthew J.
机构：
来源：
JOURNAL OF UROLOGY | 2019年 / 202卷 / 05期
关键词：
D O I：
10.1097/01.JU.0000579852.12966.fc
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：859 / 860
页数：2
相关论文
共 50 条
  • [31] Clinical relevance of ticagrelor monotherapy following 1-month dual antiplatelet therapy after bifurcation percutaneous coronary intervention: Insight from GLOBAL LEADERS trial
    Kogame, Norihiro
    Chichareon, Ply
    De Wilder, Kenneth
    Takahashi, Kuniaki
    Modolo, Rodrigo
    Chang, Chun Chin
    Tomaniak, Mariusz
    Komiyama, Hidenori
    Chieffo, Alaide
    Colombo, Antonio
    Garg, Scot
    Louvard, Yves
    Juni, Peter
    Steg, Philippe G.
    Hamm, Christian
    Vranckx, Pascal
    Valgimigli, Marco
    Windecker, Stephan
    Stoll, Hans-Peter
    Onuma, Yoshinobu
    Janssens, Luc
    Serruys, Patrick W.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2020, 96 (01) : 100 - 111
  • [32] Extended antiplatelet therapy with clopidogrel alone versus clopidogrel plus aspirin after completion of 9-to 12-month dual antiplatelet therapy for acute coronary syndrome patients with both high bleeding and ischemic risk. Rationale and design of the OPT-BIRISK double-blinded, placebo-controlled randomized trial
    Li, Yi
    Jing, Quanmin
    Wang, Bing
    Wang, Xiaozeng
    Li, Jing
    Qiao, Shubing
    Chen, Shaoliang
    Angiolillo, Dominick J.
    Han, Yaling
    AMERICAN HEART JOURNAL, 2020, 228 : 1 - 7
  • [33] Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke The ARAMIS Randomized Clinical Trial
    Chen, Hui-Sheng
    Cui, Yu
    Zhou, Zhong-He
    Zhang, Hong
    Wang, Li-Xia
    Wang, Wei-Zhong
    Shen, Li-Ying
    Guo, Li-Yan
    Wang, Er-Qiang
    Wang, Rui-Xian
    Han, Jing
    Dong, Yu-Ling
    Li, Jing
    Lin, Yong-Zhong
    Yang, Qing-Cheng
    Zhang, Li
    Li, Jing-Yu
    Wang, Jin
    Xia, Lei
    Ma, Guang-Bin
    Lu, Jiang
    Jiang, Chang-Hao
    Huang, Shu-Man
    Wan, Li-Shu
    Piao, Xiang-Yu
    Li, Zhuo
    Li, Yan-Song
    Yang, Kui-Hua
    Wang, Duo-Lao
    Nguyen, Thanh N.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (24): : 2135 - 2144
  • [34] Impact of 6-versus 12-month dual antiplatelet therapy on clinical prognosis in patients with high bleeding risk: Insights from the 4-year results of the I LOVE IT 2 study
    Zhang, Jiaoyang
    Qiu, Miaohan
    Na, Kun
    Ma, Sicong
    Jiang, Zaixin
    Li, Jing
    Li, Yi
    Han, Yaling
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2021, 97 : 1025 - 1031
  • [35] Twelve-Month Results of a Randomized Trial Comparing Mono With Dual Antiplatelet Therapy in Endovascularly Treated Patients With Peripheral Artery Disease
    Strobl, Frederik F.
    Brechtel, Klaus
    Schmehl, Joerg
    Zeller, Thomas
    Reiser, Maximilian F.
    Claussen, Claus D.
    Tepe, Gunnar
    JOURNAL OF ENDOVASCULAR THERAPY, 2013, 20 (05) : 699 - 706
  • [36] Impact of age on the comparison between short-term vs 12-month dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-Year follow-up results of the REDUCE trial
    Kedhi, Elvin
    Verdoia, Monica
    Suryapranata, Harry
    Damen, Sander
    Camaro, Cyril
    Benit, Edouard
    Barbieri, Lucia
    Rasoul, Saman
    Liew, Houng B.
    Polad, Jawed
    Ahmad, Wan A. W.
    Zambahari, Robaayah
    Lalmand, Jacques
    van der Schaaf, Rene J.
    Koh, Tian H.
    Timmermans, Philippe
    Dilling-Boer, Dagmara
    Veenstra, Leo F.
    van' t Hof, Arnoud W. J.
    Lee, Stephen W. L.
    Roolvink, Vincent
    Ligtenberg, Erik
    Postma, Sonja
    Kolkman, Evelien J. J.
    Brouwer, Marc A.
    Dudek, Dariusz
    De Luca, Giuseppe
    ATHEROSCLEROSIS, 2021, 321 : 39 - 44
  • [37] Randomized clinical trial: the impact of gastrointestinal risk factor screening and prophylactic proton pump inhibitor therapy in patients receiving dual antiplatelet therapy
    Jensen, Berit E. S.
    Hansen, Jane M.
    Larsen, Kasper S.
    Junker, Anders B.
    Lassen, Jens F.
    Jensen, Svend E.
    de Muckadell, Ove B. Schaffalitzky
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (10) : 1118 - 1125
  • [38] The Safety of 6-Month versus 12-Month Dual Antiplatelet Therapy in Patients Treated with Zotarolimus-Eluting Stent: A Patient-Level Pooled Analysis of Five ENDEAVOR Randomized Trials
    Mehran, Roxana
    Kandzari, David E.
    Mauri, Laura
    Caixeta, Adriano
    Dangas, George
    Negoita, Manuela
    Leon, Martin B.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (8A): : 168I - 169I
  • [39] Comparison of 3-to 6-Month Versus 12-Month Dual Antiplatelet Therapy After Coronary Intervention Using the Contemporary Drug-Eluting Stents With Ultrathin Struts: The HOST-IDEA Randomized Clinical Trial
    Han, Jung-Kyu
    Hwang, Doyeon
    Yang, Seokhun
    Park, Sang-Hyeon
    Kang, Jeehoon
    Yang, Han-Mo
    Park, Kyung Woo
    Kang, Hyun-Jae
    Koo, Bon-Kwon
    Hur, Seung-Ho
    Kim, Weon
    Kim, Seok Yeon
    Park, Sang-Hyun
    Han, Seung Hwan
    Kim, Sang-Hyun
    Shin, Sanghoon
    Kim, Yong Hoon
    Park, Kyungil
    Lee, Namho
    Lee, Seung Jin
    Kim, Jin Won
    Kim, Hyo-Soo
    CIRCULATION, 2023, 147 (18) : 1358 - 1368
  • [40] Impact of greater than 12-month dual antiplatelet therapy duration on mortality: Drug-specific or a class-effect? A meta-analysis
    Costa, Francesco
    Adamo, Marianna
    Ariotti, Sara
    Navarese, Eliano Pio
    Biondi-Zoccai, Giuseppe
    Valgimigli, Marco
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 201 : 179 - 181
12345